With an exclusive case-study led agenda, the European NeoAg Summit will paint a fuller picture of neoantigen presentation and T-cell interaction. Hear updates on clinical trials results to help you further determine neoantigen immunogenicity.
In addition, gain practical insights on personalised cancer vaccine and cell therapy global clinical development, as well as regulatory guidance.
Join the gathering of over 100 personalised cancer immunotherapy pioneers from pharma and biotech including Ziopharm, Genocea, Vaccibody and more to advance neoantigen based cancer vaccines and cell therapies.
For more information, visit www.neoantigen-europe.com